ATROVENT is contraindicated in patients with known hypersensitivity to atropine or its derivatives (such as the active substance ipratropium bromide) or to any other component of the product.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
